Trial
NCT02538081
Nicotinic Receptors and Schizophrenia
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
VA Office of Research and Development
Collaborators
University of Colorado, Denver
Condition
Schizophrenia
Intervention
Risperidone plus Placebo
Why stopped
Withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-30